Bladder Cancer
Latest News in Bladder Cancer
July 19, 2025
July 18, 2025
Johnson & Johnson’s TAR-200 granted FDA priority review to treat bladder cancer – PMLiVE
509 Active Bladder Cancer Clinical Trials
509 Active Bladder Cancer Clinical Trials
As of July 12, 2025
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS